Regeneron Pharmaceuticals

About Regeneron Pharmaceuticals

Regeneron Pharmaceuticals is a leading biotechnology company that focuses on the discovery, development, and commercialization of innovative medicines for serious diseases. Founded in 1988, the company has established itself as a pioneer in the field of genetic research and drug development.

With a commitment to scientific excellence, Regeneron employs cutting-edge technologies such as its proprietary VelociSuite® platform, which accelerates the process of developing new therapeutics. The company’s portfolio includes a range of products that address conditions like cancer, eye diseases, and inflammatory disorders.

Regeneron is dedicated to improving patient outcomes through rigorous clinical trials and collaborations with healthcare professionals. The company’s vision is to harness the power of science to create transformative therapies that enhance the quality of life for patients worldwide.

• Innovative Research: Regeneron invests heavily in research and development to stay at the forefront of biotechnology.
• Patient-Centric Approach: The company prioritizes patient needs in all aspects of its operations.
• Global Reach: Regeneron’s products are available in multiple countries, making a significant impact on global health.

Headquartered in Tarrytown, New York, Regeneron operates with a strong ethical framework and a commitment to sustainability. The company believes in fostering a diverse and inclusive workplace, which is essential for driving innovation and creativity.

As Regeneron continues to grow, it remains focused on its mission to deliver life-changing therapies to patients in need, ensuring that science and compassion go hand in hand.